TY - JOUR
T1 - Role of Neurohormonal Modulators in Heart Failure with Relatively Preserved Systolic Function
AU - Rapp, Jonathan A.
AU - Gheorghiade, Mihai
PY - 2005/4/1
Y1 - 2005/4/1
N2 - "Cardiovascular disease remains the leading cause of mortality in the developed world. It is estimated that 5 million Americans suffer from heart failure (HF), and roughly 550,000 new cases are diagnosed annually. Studies have found that 40% to 71% of patients who have HF have relatively preserved systolic functions, or diastolic heart failure (DHF). Although there are abundant data to guide the treatment of heart failure and systolic dysfunction, evidence-based data are lacking in the management of DHF. This article examines the role of neurohormonal modulators in the management of DHF.".
AB - "Cardiovascular disease remains the leading cause of mortality in the developed world. It is estimated that 5 million Americans suffer from heart failure (HF), and roughly 550,000 new cases are diagnosed annually. Studies have found that 40% to 71% of patients who have HF have relatively preserved systolic functions, or diastolic heart failure (DHF). Although there are abundant data to guide the treatment of heart failure and systolic dysfunction, evidence-based data are lacking in the management of DHF. This article examines the role of neurohormonal modulators in the management of DHF.".
UR - http://www.scopus.com/inward/record.url?scp=33645998768&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33645998768&partnerID=8YFLogxK
U2 - 10.1016/j.hfc.2004.10.003
DO - 10.1016/j.hfc.2004.10.003
M3 - Review article
C2 - 17386836
AN - SCOPUS:33645998768
SN - 1551-7136
VL - 1
SP - 77
EP - 93
JO - Heart Failure Clinics
JF - Heart Failure Clinics
IS - 1
ER -
